Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1992 May;68(799):327–337. doi: 10.1136/pgmj.68.799.327

Recent advances in cardiology.

C F Shakespeare 1, D J Coltart 1
PMCID: PMC2399408  PMID: 1630975

Full text

PDF
329

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong P. W., Baigrie R. S., Daly P. A., Haq A., Gent M., Roberts R. S., Freeman M. R., Burns R., Liu P., Morgan C. D. Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction. J Am Coll Cardiol. 1989 Jun;13(7):1469–1476. doi: 10.1016/0735-1097(89)90334-3. [DOI] [PubMed] [Google Scholar]
  2. Arnold A. E., Serruys P. W., Rutsch W., Simoons M. L., de Bono D. P., Tijssen J. G., Lubsen J., Verstraete M. Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis. European Cooperative Study Group. J Am Coll Cardiol. 1991 Jan;17(1):11–21. doi: 10.1016/0735-1097(91)90699-a. [DOI] [PubMed] [Google Scholar]
  3. Bashore T. M., Davidson C. J. Follow-up recatheterization after balloon aortic valvuloplasty. Mansfield Scientific Aortic Valvuloplasty Registry Investigators. J Am Coll Cardiol. 1991 Apr;17(5):1188–1195. doi: 10.1016/0735-1097(91)90853-2. [DOI] [PubMed] [Google Scholar]
  4. Berk B. C., Gordon J. B., Alexander R. W. Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty. J Am Coll Cardiol. 1991 May;17(6 Suppl B):111B–117B. doi: 10.1016/0735-1097(91)90946-7. [DOI] [PubMed] [Google Scholar]
  5. Bleich S. D., Nichols T. C., Schumacher R. R., Cooke D. H., Tate D. A., Teichman S. L. Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction. Am J Cardiol. 1990 Dec 15;66(20):1412–1417. doi: 10.1016/0002-9149(90)90525-6. [DOI] [PubMed] [Google Scholar]
  6. Boissel J. P., Leizorovicz A., Picolet H., Peyrieux J. C. Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol. Am J Cardiol. 1990 Aug 1;66(3):251–260. doi: 10.1016/0002-9149(90)90831-k. [DOI] [PubMed] [Google Scholar]
  7. Califf R. M., Topol E. J., Stack R. S., Ellis S. G., George B. S., Kereiakes D. J., Samaha J. K., Worley S. J., Anderson J. L., Harrelson-Woodlief L. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group. Circulation. 1991 May;83(5):1543–1556. doi: 10.1161/01.cir.83.5.1543. [DOI] [PubMed] [Google Scholar]
  8. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  9. Collen D. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator? Ann Intern Med. 1990 Apr 1;112(7):529–538. doi: 10.7326/0003-4819-112-7-529. [DOI] [PubMed] [Google Scholar]
  10. Cook S. L., Eigler N. L., Shefer A., Goldenberg T., Forrester J. S., Litvack F. Percutaneous excimer laser coronary angioplasty of lesions not ideal for balloon angioplasty. Circulation. 1991 Aug;84(2):632–643. doi: 10.1161/01.cir.84.2.632. [DOI] [PubMed] [Google Scholar]
  11. Currier J. W., Pow T. K., Haudenschild C. C., Minihan A. C., Faxon D. P. Low molecular weight heparin (enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit. J Am Coll Cardiol. 1991 May;17(6 Suppl B):118B–125B. doi: 10.1016/0735-1097(91)90947-8. [DOI] [PubMed] [Google Scholar]
  12. Davies S. W., Marchant B., Lyons J. P., Timmis A. D., Rothman M. T., Layton C. A., Balcon R. Coronary lesion morphology in acute myocardial infarction: demonstration of early remodeling after streptokinase treatment. J Am Coll Cardiol. 1990 Nov;16(5):1079–1086. doi: 10.1016/0735-1097(90)90535-w. [DOI] [PubMed] [Google Scholar]
  13. Detre K. M., Holmes D. R., Jr, Holubkov R., Cowley M. J., Bourassa M. G., Faxon D. P., Dorros G. R., Bentivoglio L. G., Kent K. M., Myler R. K. Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1990 Sep;82(3):739–750. doi: 10.1161/01.cir.82.3.739. [DOI] [PubMed] [Google Scholar]
  14. Detre K., Holubkov R., Kelsey S., Cowley M., Kent K., Williams D., Myler R., Faxon D., Holmes D., Jr, Bourassa M. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. N Engl J Med. 1988 Feb 4;318(5):265–270. doi: 10.1056/NEJM198802043180501. [DOI] [PubMed] [Google Scholar]
  15. Ellis S. G., Vandormael M. G., Cowley M. J., DiSciascio G., Deligonul U., Topol E. J., Bulle T. M. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990 Oct;82(4):1193–1202. doi: 10.1161/01.cir.82.4.1193. [DOI] [PubMed] [Google Scholar]
  16. Faller D. V., Kourembanas S., Ginsberg D., Hannan R., Collins T., Ewenstein B. M., Pober J. S., Tantravahi R. Immortalization of human endothelial cells by murine sarcoma viruses, without morphologic transformation. J Cell Physiol. 1988 Jan;134(1):47–56. doi: 10.1002/jcp.1041340106. [DOI] [PubMed] [Google Scholar]
  17. Frishman W. H., Lazar E. J. Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockade. Am J Cardiol. 1990 Nov 6;66(16):66G–70G. doi: 10.1016/0002-9149(90)90401-l. [DOI] [PubMed] [Google Scholar]
  18. Hodgson J. M., Graham S. P., Sheehan H., Savakus A. D. Percutaneous intracoronary ultrasound imaging: initial applications in patients. Echocardiography. 1990 Jul;7(4):403–413. doi: 10.1111/j.1540-8175.1990.tb00381.x. [DOI] [PubMed] [Google Scholar]
  19. Hsia J., Hamilton W. P., Kleiman N., Roberts R., Chaitman B. R., Ross A. M. A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators. N Engl J Med. 1990 Nov 22;323(21):1433–1437. doi: 10.1056/NEJM199011223232101. [DOI] [PubMed] [Google Scholar]
  20. Jackman W. M., Wang X. Z., Friday K. J., Roman C. A., Moulton K. P., Beckman K. J., McClelland J. H., Twidale N., Hazlitt H. A., Prior M. I. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med. 1991 Jun 6;324(23):1605–1611. doi: 10.1056/NEJM199106063242301. [DOI] [PubMed] [Google Scholar]
  21. Kahn J. K., Rutherford B. D., McConahay D. R., Johnson W. L., Giorgi L. V., Shimshak T. M., Ligon R. W., Hartzler G. O. Catheterization laboratory events and hospital outcome with direct angioplasty for acute myocardial infarction. Circulation. 1990 Dec;82(6):1910–1915. doi: 10.1161/01.cir.82.6.1910. [DOI] [PubMed] [Google Scholar]
  22. Karsch K. R., Haase K. K., Voelker W., Baumbach A., Mauser M., Seipel L. Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris. Acute results and incidence of restenosis during 6-month follow-up. Circulation. 1990 Jun;81(6):1849–1859. doi: 10.1161/01.cir.81.6.1849. [DOI] [PubMed] [Google Scholar]
  23. Klein L. S., Miles W. M., Zipes D. P. Antitachycardia devices: realities and promises. J Am Coll Cardiol. 1991 Nov 1;18(5):1349–1362. doi: 10.1016/0735-1097(91)90559-r. [DOI] [PubMed] [Google Scholar]
  24. Lee L., Erbel R., Brown T. M., Laufer N., Meyer J., O'Neill W. W. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol. 1991 Mar 1;17(3):599–603. doi: 10.1016/s0735-1097(10)80171-8. [DOI] [PubMed] [Google Scholar]
  25. Lee M. A., Morady F., Kadish A., Schamp D. J., Chin M. C., Scheinman M. M., Griffin J. C., Lesh M. D., Pederson D., Goldberger J. Catheter modification of the atrioventricular junction with radiofrequency energy for control of atrioventricular nodal reentry tachycardia. Circulation. 1991 Mar;83(3):827–835. doi: 10.1161/01.cir.83.3.827. [DOI] [PubMed] [Google Scholar]
  26. Lefèvre T., Bonan R., Serra A., Crépeau J., Dyrda I., Petitclerc R., Leclerc Y., Vanderperren O., Waters D. Percutaneous mitral valvuloplasty in surgical high risk patients. J Am Coll Cardiol. 1991 Feb;17(2):348–354. doi: 10.1016/s0735-1097(10)80098-1. [DOI] [PubMed] [Google Scholar]
  27. Lin H., Parmacek M. S., Morle G., Bolling S., Leiden J. M. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation. 1990 Dec;82(6):2217–2221. doi: 10.1161/01.cir.82.6.2217. [DOI] [PubMed] [Google Scholar]
  28. Lundergan C. F., Foegh M. L., Ramwell P. W. Peptide inhibition of myointimal proliferation by angiopeptin, a somatostatin analogue. J Am Coll Cardiol. 1991 May;17(6 Suppl B):132B–136B. doi: 10.1016/0735-1097(91)90949-a. [DOI] [PubMed] [Google Scholar]
  29. Magnani B. Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol. 1989 Jan;13(1):19–26. doi: 10.1016/0735-1097(89)90543-3. [DOI] [PubMed] [Google Scholar]
  30. Marmur J. D., Sanborn T. A., Kahn H., Badimon J. J., Badimon L., Fuster V. Acute biologic response to excimer versus thermal laser angioplasty in experimental atherosclerosis. J Am Coll Cardiol. 1991 Mar 15;17(4):978–984. doi: 10.1016/0735-1097(91)90883-b. [DOI] [PubMed] [Google Scholar]
  31. Matsuzaki M., Toma Y., Kusukawa R. Clinical applications of transesophageal echocardiography. Circulation. 1990 Sep;82(3):709–722. doi: 10.1161/01.cir.82.3.709. [DOI] [PubMed] [Google Scholar]
  32. McCowan R., Maloney J., Wilkoff B., Simmons T., Khoury D., McAlister H., Morant V., Castle L. Automatic implantable cardioverter-defibrillator implantation without thoracotomy using an endocardial and submuscular patch system. J Am Coll Cardiol. 1991 Feb;17(2):415–421. doi: 10.1016/s0735-1097(10)80108-1. [DOI] [PubMed] [Google Scholar]
  33. McKay R. G. The Mansfield Scientific Aortic Valvuloplasty Registry: overview of acute hemodynamic results and procedural complications. J Am Coll Cardiol. 1991 Feb;17(2):485–491. doi: 10.1016/s0735-1097(10)80120-2. [DOI] [PubMed] [Google Scholar]
  34. Meinertz T., Kasper W., Schumacher M., Just H. The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction. Am J Cardiol. 1988 Sep 1;62(7):347–351. doi: 10.1016/0002-9149(88)90956-3. [DOI] [PubMed] [Google Scholar]
  35. Morady F., Kadish A. H., DiCarlo L., Kou W. H., Winston S., deBuitlier M., Calkins H., Rosenheck S., Sousa J. Long-term results of catheter ablation of idiopathic right ventricular tachycardia. Circulation. 1990 Dec;82(6):2093–2099. doi: 10.1161/01.cir.82.6.2093. [DOI] [PubMed] [Google Scholar]
  36. Morgan C. D., Roberts R. S., Haq A., Baigrie R. S., Daly P. A., Gent M., Armstrong P. W. Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study Group. J Am Coll Cardiol. 1991 Jun;17(7):1451–1457. doi: 10.1016/0735-1097(91)90630-r. [DOI] [PubMed] [Google Scholar]
  37. Muller D. W., Ellis S. G., Topol E. J. Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions. J Am Coll Cardiol. 1991 May;17(6 Suppl B):126B–131B. doi: 10.1016/0735-1097(91)90948-9. [DOI] [PubMed] [Google Scholar]
  38. Nabel E. G., Plautz G., Boyce F. M., Stanley J. C., Nabel G. J. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science. 1989 Jun 16;244(4910):1342–1344. doi: 10.1126/science.2499928. [DOI] [PubMed] [Google Scholar]
  39. Nabel E. G., Plautz G., Nabel G. J. Gene transfer into vascular cells. J Am Coll Cardiol. 1991 May;17(6 Suppl B):189B–194B. doi: 10.1016/0735-1097(91)90957-b. [DOI] [PubMed] [Google Scholar]
  40. Nabel E. G., Plautz G., Nabel G. J. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 1990 Sep 14;249(4974):1285–1288. doi: 10.1126/science.2119055. [DOI] [PubMed] [Google Scholar]
  41. Nishimura R. A., Holmes D. R., Jr, Michela M. A. Follow-up of patients with low output, low gradient hemodynamics after percutaneous balloon aortic valvuloplasty: the Mansfield Scientific Aortic Valvuloplasty Registry. J Am Coll Cardiol. 1991 Mar 1;17(3):828–833. doi: 10.1016/s0735-1097(10)80204-9. [DOI] [PubMed] [Google Scholar]
  42. Nobuyoshi M., Kimura T., Ohishi H., Horiuchi H., Nosaka H., Hamasaki N., Yokoi H., Kim K. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol. 1991 Feb;17(2):433–439. doi: 10.1016/s0735-1097(10)80111-1. [DOI] [PubMed] [Google Scholar]
  43. Pandian N. G. Intravascular imaging. Echocardiography. 1990 Jul;7(4):375–376. doi: 10.1111/j.1540-8175.1990.tb00377.x. [DOI] [PubMed] [Google Scholar]
  44. Pfeffer M. A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990 Apr;81(4):1161–1172. doi: 10.1161/01.cir.81.4.1161. [DOI] [PubMed] [Google Scholar]
  45. Powell J. S., Muller R. K., Baumgartner H. R. Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 1991 May;17(6 Suppl B):137B–142B. doi: 10.1016/0735-1097(91)90950-e. [DOI] [PubMed] [Google Scholar]
  46. Reeder G. S., Nishimura R. A., Holmes D. R., Jr Patient age and results of balloon aortic valvuloplasty: the Mansfield Scientific Registry experience. The Mansfield Scientific Aortic Valvuloplasty Registry Investigators. J Am Coll Cardiol. 1991 Mar 15;17(4):909–913. doi: 10.1016/0735-1097(91)90873-8. [DOI] [PubMed] [Google Scholar]
  47. Ritchie J. L., Hansen D. D., Johnson C., Vracko R., Auth D. C. Combined mechanical and chemical thrombolysis in an experimental animal model: evaluation by angiography and angioscopy. Am Heart J. 1990 Jan;119(1):64–72. doi: 10.1016/s0002-8703(05)80083-3. [DOI] [PubMed] [Google Scholar]
  48. Rogers W. J., Baim D. S., Gore J. M., Brown B. G., Roberts R., Williams D. O., Chesebro J. H., Babb J. D., Sheehan F. H., Wackers F. J. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation. 1990 May;81(5):1457–1476. doi: 10.1161/01.cir.81.5.1457. [DOI] [PubMed] [Google Scholar]
  49. Sanborn T. A. Early limitations of coronary excimer laser angioplasty. J Am Coll Cardiol. 1991 Mar 15;17(4):995–996. doi: 10.1016/0735-1097(91)90886-e. [DOI] [PubMed] [Google Scholar]
  50. Sanborn T. A., Torre S. R., Sharma S. K., Hershman R. A., Cohen M., Sherman W., Ambrose J. A. Percutaneous coronary excimer laser-assisted balloon angioplasty: initial clinical and quantitative angiographic results in 50 patients. J Am Coll Cardiol. 1991 Jan;17(1):94–99. doi: 10.1016/0735-1097(91)90709-i. [DOI] [PubMed] [Google Scholar]
  51. Sane D. C., Stump D. C., Topol E. J., Sigmon K. N., Kereiakes D. J., George B. S., Mantell S. J., Macy E., Collen D., Califf R. M. Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction. Thromb Haemost. 1991 Mar 4;65(3):275–279. [PubMed] [Google Scholar]
  52. Schatz R. A., Goldberg S., Leon M., Baim D., Hirshfeld J., Cleman M., Ellis S., Topol E. Clinical experience with the Palmaz-Schatz coronary stent. J Am Coll Cardiol. 1991 May;17(6 Suppl B):155B–159B. doi: 10.1016/0735-1097(91)90952-6. [DOI] [PubMed] [Google Scholar]
  53. Scheinman M. M. Catheter ablation. Present role and projected impact on health care for patients with cardiac arrhythmias. Circulation. 1991 May;83(5):1489–1498. doi: 10.1161/01.cir.83.5.1489. [DOI] [PubMed] [Google Scholar]
  54. Serruys P. W., Strauss B. H., Beatt K. J., Bertrand M. E., Puel J., Rickards A. F., Meier B., Goy J. J., Vogt P., Kappenberger L. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med. 1991 Jan 3;324(1):13–17. doi: 10.1056/NEJM199101033240103. [DOI] [PubMed] [Google Scholar]
  55. Sharpe N., Murphy J., Smith H., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1988 Feb 6;1(8580):255–259. doi: 10.1016/s0140-6736(88)90347-9. [DOI] [PubMed] [Google Scholar]
  56. Simoons M. L., Arnold A. E., Betriu A., de Bono D. P., Col J., Dougherty F. C., von Essen R., Lambertz H., Lubsen J., Meier B. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet. 1988 Jan 30;1(8579):197–203. doi: 10.1016/s0140-6736(88)91062-8. [DOI] [PubMed] [Google Scholar]
  57. Song S. L. Performance of implantable cardiac rhythm management devices. Pacing Clin Electrophysiol. 1990 Oct;13(10):1347–1349. doi: 10.1111/j.1540-8159.1990.tb02036.x. [DOI] [PubMed] [Google Scholar]
  58. Spears J. R., Kundu S. K., McMath L. P. Laser balloon angioplasty: potential for reduction of the thrombogenicity of the injured arterial wall and for local application of bioprotective materials. J Am Coll Cardiol. 1991 May;17(6 Suppl B):179B–188B. doi: 10.1016/0735-1097(91)90956-a. [DOI] [PubMed] [Google Scholar]
  59. Talley J. D., Weintraub W. S., Roubin G. S., Douglas J. S., Jr, Anderson H. V., Jones E. L., Morris D. C., Liberman H. A., Craver J. M., Guyton R. A. Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 years. Circulation. 1990 Oct;82(4):1203–1213. doi: 10.1161/01.cir.82.4.1203. [DOI] [PubMed] [Google Scholar]
  60. Topol E. J., George B. S., Kereiakes D. J., Stump D. C., Candela R. J., Abbottsmith C. W., Aronson L., Pickel A., Boswick J. M., Lee K. L. A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction. Circulation. 1989 Feb;79(2):281–286. doi: 10.1161/01.cir.79.2.281. [DOI] [PubMed] [Google Scholar]
  61. Weintraub W. S., Jones E. L., King S. B., 3rd, Craver J., Douglas J. S., Jr, Guyton R., Liberman H., Morris D. Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease. Am J Cardiol. 1990 Jan 15;65(3):183–188. doi: 10.1016/0002-9149(90)90082-c. [DOI] [PubMed] [Google Scholar]
  62. White H. D., Rivers J. T., Maslowski A. H., Ormiston J. A., Takayama M., Hart H. H., Sharpe D. N., Whitlock R. M., Norris R. M. Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction. N Engl J Med. 1989 Mar 30;320(13):817–821. doi: 10.1056/NEJM198903303201301. [DOI] [PubMed] [Google Scholar]
  63. Wolinsky H., Lin C. S. Use of the perforated balloon catheter to infuse marker substances into diseased coronary artery walls after experimental postmortem angioplasty. J Am Coll Cardiol. 1991 May;17(6 Suppl B):174B–178B. doi: 10.1016/0735-1097(91)90955-9. [DOI] [PubMed] [Google Scholar]
  64. Yamagishi M., Yasu T., Ohara K., Kuro M., Miyatake K. Detection of coronary blood flow associated with left main coronary artery stenosis by transesophageal Doppler color flow echocardiography. J Am Coll Cardiol. 1991 Jan;17(1):87–93. doi: 10.1016/0735-1097(91)90708-h. [DOI] [PubMed] [Google Scholar]
  65. Yoshida K., Yoshikawa J., Yamaura Y., Hozumi T., Akasaka T., Fukaya T. Assessment of mitral regurgitation by biplane transesophageal color Doppler flow mapping. Circulation. 1990 Oct;82(4):1121–1126. doi: 10.1161/01.cir.82.4.1121. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES